Skip to main content

Table 2 Cardiometabolic phenotype

From: The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

  

all patients

Q I

Q II

Q III

Q IV

Q V

P

n

 

340

68

68

68

68

68

 

body mass index

kg. m-2

30.3 (6.6)

26.6 (4.9)

28.9 (6.5)

31.6 (5.8)

31.2 (6.8)

33.2 (6.8)

<0.0001

weight

kg

78.5 (17.4)

69.4 (14.3)

75.9 (17.7)

81.1 (14.5)

81.3 (17.9)

84.9 (18.3)

<0.0001

waist circumference

cm

100 (15)

90 (12)

99 (13)

104 (13)

103 (16)

107 (14)

<0.0001

fat mass

%

41.0 (6.8)

38.5 (7.8)

40.1 (6.7)

42.9 (5.4)

41.2 (6.7)

42.5 (6.2)

0.0006

conicity index

m2.kg-1

1.32 (0.10)

1.27 (0.10)

1.32 (0.08)

1.34 (0.09)

1.34 (0.10)

1.36 (0.10)

<0.0001

waist. height-1

 

0.62 (0.10)

0.56 (0.08)

0.61 (0.08)

0.65 (0.09)

0.64 (0.11)

0.67 (0.09)

<0.0001

visceral fat

0-30 score

10 (3)

8 (3)

9 (3)

11 (3)

11 (3)

11 (3)

<0.0001

fat free mass index

kg.m-2

17.8 (3.4)

17.2 (3.9)

17.3 (3.3)

18.1 (2.3)

17.8 (3.5)

18.8 (3.5)

0.0377

HOMA S

%

57 (42)

82 (52)

67 (45)

46 (34)

45 (26)

39 (30)

<0.0001

HOMA B

%

65 (48)

55 (40)

54 (31)

77 (63)

70 (45)

70 (53)

0.0158

HOMA product [BxS]

%

28.6 (18.5)

35.9 (21.1)

30.6 (20.3)

26.8 (18.0)

25.9 (11.9)

22.5 (17.1)

<0.0001

[BxS] loss rate

%.yr-1

1.29 (0.51)

1.17 (0.53)

1.22 (0.47)

1.30 (0.47)

1.26 (0.29)

1.52 (0.68)

0.0008

fasting insulinaemia

pmol.1-1

114 (72)

77 (48)

103 (78)

126 (80)

127 (69)

141 (69)

<0.0001

metabolic syndrome

%

86

59

82

94

94

100

<0.0001

metabolic syndrome score

0/5 to 5/5

3.7 (1.1)

2.6 (1.0)

3.3 (0.9)

3.8 (0.8)

4.3 (0.9)

4.7 (0.6)

<0.0001

liver steatosis

%

64

27

55

76

80

83

<0.0001

  1. Results are expressed as means (1 SD) or proportions (%). HOMA S and HOMA B: insulin sensitivity and β-cell function determined from Homeostatic Model Assessment. Q: quintile.